ESPE Abstracts

Background: Childhood obesity has fast become one of the greatest challenges faced by public health. Recent NHS figures (2018) state over one fifth of all year 6 students in the UK were living with obesity. This has consequences for health-care resources, but more importantly affects young people’s physical and mental wellbeing. Liraglutide (Saxenda), a glucagon-like peptide-1 agonist, has been proven to reduce blood glucose, markers of adiposity and sup...